Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
For patients experiencing restless leg symptoms while taking semaglutide, a systematic approach to evaluation and management is essential
Using GLP-1RAs instead of insulin cost US$54,851 and US$29,115 per case of all-cause mortality and hospitalized hypoglycemia prevented, respectively, from the payer perspective, and saved US$19,391 and US$10,293, respectively, from the healthcare sector perspective
2B and 5)
The medication is a tool
US$ 21.24
US$ 29.65
US$ 20.46
US$ 20.73
US$ 23.70
US$ 29.72
US$ 26.64
US$ 27.87
US$ 26.60
